• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Ipca Laboratories Ltd.
    29 May 2025
    1311.50
    0.09%
    Ipca Laboratories Q4 net profit up 14% at 68 crore
    Business Line
    The drug firm reported a net profit of 60 crore during the January-March quarter of 2023-24 financial year
    Copy LinkShare onShare on Share on Share on
    Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
    logo
    AstraZeneca Pharma India Ltd.
    29 May 2025
    9016.50
    0.08%
    AstraZeneca gets CDSCO nod for lung cancer drug
    Business Line
    The company has received approval from the Central Drugs Standard Control Organisation, for Osimertinib tablets in strength of 40mg and 80mg, AstraZeneca India said in a statement
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. has gained 32.60% in the last 1 Year
    logo
    Natco Pharma Ltd.
    29 May 2025
    852.15
    0.09%
    Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29
    Business Standard
    Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
    Natco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook Gloomy
    NDTV Profit | 28 May 2025 1 more
    Natco Pharma's Q4 net up 4.9% at 406 cr
    Business Line | 28 May 2025
    logo
    Granules India Ltd.
    29 May 2025
    539.80
    1.21%
    Granules India Q4 Review: Motilal Oswal Maintains 'Buy' Post Inline Results, But Cuts Target Price
    Granules India Q4 Review: Motilal Oswal Maintains 'Buy' Post Inline Results, But Cuts Target Price
    NDTV Profit
    Gagillapur remediation, Senn integration weigh on near-term profitability, says Motilal Oswal
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. has an average target of 608.00 from 4 brokers.
    Granules India Q4 results: Net profit jumps 17% to 152 cr
    Business Line | 28 May 2025
    logo
    Laurus Labs Ltd.
    27 May 2025
    894.85
    -0.02%
    Mahindra & Mahindra, Laurus Labs Check Shrikant Chouhan's Top Picks
    Mahindra & Mahindra, Laurus Labs Check Shrikant Chouhan's Top Picks
    NDTV Profit
    These recommendations come with specific target prices and stop-loss levels, providing clear guidance for potential investments.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.24% in the last 3 Months
    logo
    Orchid Pharma Ltd.
    27 May 2025
    709.40
    0.04%
    Orchid Pharma Q4 Results Review: A Strong Start For Enemetazobactam In India; Systematix Maintains 'Buy'
    Orchid Pharma Q4 Results Review: A Strong Start For Enemetazobactam In India; Systematix Maintains 'Buy'
    NDTV Profit
    Based on Systematix' revised forecasts, retains Buy with a target price of Rs 1,112.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 94 to 60 in Jun 2025 qtr
    logo
    Bajaj Healthcare Ltd.
    27 May 2025
    Dividend
    435.80
    2.38%
    Bajaj Healthcare slips 9% on weak Q4 operational performance; details here
    Business Standard
    Bajaj Healthcare share price dropped today on the back of weak operational performance in the March quarter of FY25 (Q4FY25).
    Copy LinkShare onShare on Share on Share on
    Bajaj Healthcare Ltd. is trading below all available SMAs
    logo
    Lincoln Pharmaceuticals Ltd.
    27 May 2025
    553.65
    0.03%
    Lincoln Pharmaceuticals targets 1000 crore revenues in next 3 years
    Business Line
    During FY25, thecompany revenues grew by 5%year-on-year to 647 crore with states like Uttar Pradesh, Assam and Odisha making the maximumcontribution to the revenues from the domestic market
    Copy LinkShare onShare on Share on Share on
    Lincoln Pharmaceuticals Ltd. has lost -27.77% in the last 1 Year
    logo
    Aurobindo Pharma Ltd.
    27 May 2025
    1091.60
    -0.77%
    Aurobindo Pharma Share Price Rises After Q4 Revenue Growth
    Aurobindo Pharma Share Price Rises After Q4 Revenue Growth
    NDTV Profit
    Aurobindo Pharma reported a consolidated revenue increase of 10.6% year-on-year, reaching Rs 8,382 crore in Q4 FY25.
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
    Aurobindo Pharma Q4 results: Profit dips to 903 cr, revenue up 11%
    Business Standard | 26 May 2025 5 more
    Aurobindo Pharma Q4 net dips 0.5%, revenue up 10.5% to Rs 8,382 cr
    Business Standard | 26 May 2025
    Aurobindo Pharma's Q4 net down marginally to 903 crore
    Business Line | 26 May 2025
    Aurobindo Pharma Q4 PAT falls marginally to 903 cr, revenue up 10%
    Business Standard | 26 May 2025
    Aurobindo Pharma Q4 result: PAT falls marginally to 903 cr, revenue up 10%
    Business Standard | 26 May 2025
    Aurobindo Pharma Q4 Results: Profit Stays Flat, Misses Estimates
    NDTV Profit | 26 May 2025
    logo
    Lupin Ltd.
    26 May 2025
    2051.80
    0.28%
    Lupin signs licensing deal with SteinCares for ranibizumab in LatAm
    Business Standard
    Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding Mexico and Argentina
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    Lupin inks licence agreement to commercialise biosimilar in Latin America
    Business Line | 26 May 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • L T Elevator
    • TechD Cybersecurity
    • Euro Pratik Sales
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd